Loading EYE company information
Open the financials tab to load SEC data
Loading EYE data
Loading EYE data
Loading EYE data
Loading EYE data
Loading EYE data
Few overheating or already-surging signals — relatively calm. A good stage to observe pre-breakout conditions patiently.
Some risk factors present — volatility, short-term overheating, or thin liquidity. Size and scale in carefully if entering.
Already surged, RSI overheated, extended far from highs, or earnings imminent. Chasing now carries meaningful pullback risk.
EYE's RSI(14) currently reads 67. RSI compares the size of recent up moves to down moves to flag stretched conditions in either direction. Readings above 70 are typically read as overbought and below 30 as oversold — this one falls in the 'normal' range. Cross-check this against EYE's other indicators above before drawing a conclusion. → Learn more
ADX currently reads 32. ADX is a strength-only gauge: it rises when a move is sustained, regardless of which way it points (25+ is considered pronounced). Right now EYE shows +DI sits above -DI, favoring the upside, putting it in the 'strong trend' range on ADX. Cross-check this against EYE's other indicators above before drawing a conclusion. → Learn more
EYE's Bollinger Band width is in the bottom 30% (narrow) of its past year, and the squeeze indicator is not currently active. A squeeze flags that band width has narrowed to a low percentile versus its own trailing history. A squeeze is often followed by a volatility expansion in either direction. As with any single metric, weigh this alongside EYE's full indicator set. → Learn more
EYE's OBV is currently rising (1.2x), and the up/down volume ratio is 1.2x. OBV is a running tally that infers buying or selling pressure purely from volume direction. As with any single metric, weigh this alongside EYE's full indicator set. → Learn more
EYE's recent volume is running at 0.7x its usual level. This figure flags whether trading activity has picked up relative to its own recent norm — a reference point for whether order flow is concentrating around this stock. As with any single metric, weigh this alongside EYE's full indicator set. → Learn more
EYE's change over the last 5 trading days is +7.1%, and over the last 1 trading day is -1.1%. Both are backward-looking price-change figures, not a forecast of future movement.
EYE's current price is 1.1% below its 20-day high. It shows how much room remains between the current price and its own 20-day high-water mark. On this measure it currently falls in the 'near resistance' category. Cross-check this against EYE's other indicators above before drawing a conclusion. → Learn more
EYE's ATR% currently reads 3.7%, a 'daily range' level. ATR (Average True Range) measures the average size of a stock's daily price swings. As with any single metric, weigh this alongside EYE's full indicator set. → Learn more
EYE's 20-trading-day relative strength versus SPY (S&P 500 ETF) is +14.4%. This means the stock's return beat SPY's return over the same window. This reading is specific to EYE on this scan date and can change quickly. → Learn more
No significant edge was measured for OBV Accumulation: 24.7% versus a 24.7% base rate across 9096 cases. Cross-check this against EYE's other indicators above before drawing a conclusion. → OBV Accumulation
Stocks holding ADX Trend Strengthening reached +15% 24.5% of the time, versus a 24.7% base rate — not a statistically significant difference (11420 cases). Cross-check this against EYE's other indicators above before drawing a conclusion. → ADX Trend Strengthening
No significant edge was measured for +DI Dominance: 24.6% versus a 24.7% base rate across 12815 cases. This reading is specific to EYE on this scan date and can change quickly. → +DI Dominance
Measured (n=8568), the hit-rate for Weekly Squeeze (22.3%) was not statistically distinguishable from the base rate (24.7%). Treat this as one data point on EYE, not a standalone signal. → Weekly Squeeze
Stocks holding Relative Strength +8pp (20D) reached +15% 31.7% of the time, versus a 24.7% base rate — not a statistically significant difference (5325 cases). Treat this as one data point on EYE, not a standalone signal. → Relative Strength +8pp (20D)
Limitations of this page — Automatically calculated, not a stock recommendation. Score is a count of conditions met, not a prediction; base rates are historical measurements only (EYE diagnostic as of 2026.10.24 17:21).